First identified in 1989, eosinophilia-myalgia syndrome is a rare condition that produces inflammation in the muscles, lungs, and skin. Patients with this syndrome also have elevated levels of ...

People with e-asthma have too many infection-fighting white blood cells called eosinophils in their lung tissue, blood, and mucus. These cells are ready to react to a threat. If the cells are ...

is a severe form of asthma that causes high levels of eosinophils in the lung tissue, blood, and mucus. Eosinophils are a type of immune system cell that typically help your body fight infections.

Laboratory tests showed elevated eosinophils, lymphocytes, and immunoglobulins, along with thrombocytopenia. Imaging revealed focal low-density areas in the lungs and erythematous lesions on the ...

a condition when there are too many eosinophils, a type of white blood cell. The third phase is vasculitis, usually involving the skin, lungs, nerves, kidneys, and other organs. There is frequent ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...

Dupixent (dupilumab) is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available ...

Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...

Immunodeficiency disorders linked to cytoskeleton defects are rare and complex, often presenting with diverse clinical ...

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...